ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.29	12.6	5.88	16.94	0.81
Short-Term Investments	0.03	0.03	0.04	0.04	0.06
Cash & Short-Term Investments	13.32	12.63	5.92	16.98	0.87
Cash Growth	5.49%	113.36%	-65.14%	1857.25%	-33.93%
Other Receivables	0.08	0.08	0.07	0.05	0.03
Receivables	0.08	0.08	0.07	0.05	0.03
Prepaid Expenses	0.37	0.53	0.56	0.12	0.04
Other Current Assets	5.13	0.38	0.35	0.56	0.03
Total Current Assets	18.91	13.62	6.9	17.71	0.97
Property, Plant & Equipment	-	-	0	0	0.08
Long-Term Investments	-	-	-	-	0
Other Intangible Assets	-	-	0.02	0.03	0.03
Total Assets	18.91	13.62	6.92	17.75	1.09
Accounts Payable	1.74	7.84	2.98	0.41	0.44
Accrued Expenses	0.48	1.51	3.44	0.52	1.45
Total Current Liabilities	2.22	9.35	6.41	0.93	1.88
Long-Term Debt	-	-	-	3.91	-
Other Long-Term Liabilities	0.2	0.52	1.86	7.25	-
Total Liabilities	2.42	9.87	8.27	12.09	1.88
Common Stock	-	-	-	-	41.39
Additional Paid-In Capital	107.55	97.59	79.1	68.04	6.55
Retained Earnings	-90.69	-93.47	-80.25	-62.19	-55.92
Comprehensive Income & Other	-0.37	-0.37	-0.2	-0.19	7.17
Shareholders' Equity	16.49	3.75	-1.35	5.66	-0.8
Total Liabilities & Equity	18.91	13.62	6.92	17.75	1.09
Total Debt	-	-	-	3.91	-
Net Cash (Debt)	13.32	12.63	5.92	13.08	0.87
Net Cash Growth	5.49%	113.36%	-54.73%	1407.11%	-33.93%
Net Cash Per Share	0.50	1.03	0.79	2.26	0.18
Filing Date Shares Outstanding	32.69	18.96	8.58	7.2	5.1
Total Common Shares Outstanding	32.69	18.89	8.58	7.2	4.83
Working Capital	16.69	4.27	0.49	16.79	-0.91
Book Value Per Share	0.50	0.20	-0.16	0.79	-0.17
Tangible Book Value	16.49	3.75	-1.37	5.63	-0.83
Tangible Book Value Per Share	0.50	0.20	-0.16	0.78	-0.17
Machinery	-	-	-	0.08	0.16

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q